Research Programs


The Human Papillomavirus (HPV) vaccine and prevention of cervical cancer


Natural and vaccine induced immune responses to H1NI Virus


Understanding measles vaccine failure (and success in Southern India)

Past Research


Immunobiology of Cervical Cancer


Histogenesis of cervical cancer


Human papillomaviruses and development of epithelial cancer


Cancer Stem Cell Research

Current Research Grants

  • 2021 2009

    Accurate and satisfactory analysis of all high risk HPV types and some of the low risks including HPV 6 and 11 antibody titers for the 2-versus 3 dose HPV vaccination clinical trial in India.
    Bill & Melinda Gates Foundation and International Agency for Research on Cancer of the World Health Organization
    Rs.1.20 Crores per year for 12 years

  • 2021 2018

    Glue Grant: Biomarkers of Oral Cancer Prediction
    Department of Biotechnology [DBT]

  • 2021 2017

    Understanding Measles Vaccine Failure (and success) in Southern India
    National Institutes of Health [NIH]
    Rs. 65 lakhs per year for 5 years

  • 2020 2017

    Program Support on Translational Research in Triple Negative Breast Cancer (Center of Excellence)
    Department of Biotechnology [DBT]
    Rs. 2,90,18,600

  • 2019 2016

    Role of Human Papillomavirus Infection and other co-factors in the aetiology of the Head and Neck Cancer in India
    Indian Council of Medical Research [ICMR]
    Rs. 1,20,51,000

  • 2019 2016

    National Facility for Drug Discovery and Developmental Therapeutics (NFDDDT)
    Department of Science & Technology [DST]
    Rs. 4,49,49,512

Research Grants Completed


Rajiv Gandhi Centre for Biotechnology (RGCB),
Thycaud Post, Poojappura,
Thiruvananthapuram - 695 014, Kerala, India
+91-471-2529400 | 2347975 | 2348753

My Gov Prime Ministers National Relife Fund India Gov Make In India Make In India Data gov in

Last Updated on: August 08, 2020
CERT-In Certified Website